Navigation Links
Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
Date:11/8/2007

s of current and future collaborative relationships, the market acceptance of our products, our ability to compete with larger, better financed pharmaceutical and biotechnology companies, new approaches to the treatment of our targeted diseases, our expectation of incurring continued losses, our uncertainty of product revenues and profits, our ability to generate future revenues, our ability to raise additional capital to continue our drug development programs, the success of our clinical trials, our ability to develop and commercialize products, our ability to obtain required regulatory approvals, our compliance with all Food and Drug Administration regulations, our ability to obtain, maintain and protect intellectual property rights for our products, the risk of litigation regarding our intellectual property rights, our limited sales and manufacturing capabilities, our dependence on third-party manufacturers and value added resellers, our ability to hire and retain skilled personnel, our volatile stock price, and other risks detailed in Repligen's filings with the Securities and Exchange Commission. Repligen assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.


'/>"/>
SOURCE Repligen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... AUSTIN, Texas , March 3, 2015  UnaliWear ... that provides advanced support for seniors that guards against ... The new wearable – the Kanega ... of its kind to use an easy speech interface ... update medical information without human input. ...
(Date:3/3/2015)... , March 3, 2015 Konica Minolta ... announced today a new, integrated portable X-ray ... solution is now available with a larger integrated console, ... mounted system offers a larger viewing area to simplify ... provides additional space for accessories and storage, along with ...
(Date:3/3/2015)... , March 3, 2015 Frost ... recognized world-class manufacturing companies and individual leaders ... Awards. Logo - http://photos.prnewswire.com/prnh/20150303/179222LOGO ... intensifying global competition and accelerating, technology-driven change, ... themselves by embracing breakthrough innovation and enabling ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 32015 Manufacturing Leadership Award Winners Announced 22015 Manufacturing Leadership Award Winners Announced 32015 Manufacturing Leadership Award Winners Announced 42015 Manufacturing Leadership Award Winners Announced 52015 Manufacturing Leadership Award Winners Announced 6
... UCB, Inc. today announced an agreement with the U.S. ... investigation into the marketing and promotion of Keppra®, an anti-epileptic ... subject of this investigation occurred more than six years ago, ... with the United States since learning of the investigation in ...
... hoc analysis from the RECOVER study (Randomized Evaluation of ... that patients with Parkinson,s disease who used Neupro® (rotigotine ... mood/cognition, such as taking interest in surroundings and getting ... presented from a one year open label follow-up of ...
Cached Medicine Technology:UCB, Inc. Resolves Investigation of Past Keppra® Marketing and Promotional Activities 2Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 2Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 3Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 4Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 5Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 6
(Date:3/3/2015)... Today is International Ear Care Day, ... occasion to applaud and promote the launch of Make ... Organization (WHO) for stemming the threat of noise-induced hearing ... people to practice safe listening when they recreate, be ... sporting events, or engaging in other forms of entertainment. ...
(Date:3/3/2015)... The number of couples experiencing infertility in Canada ... increases to 50% by the time a woman is ... et al. Estimating the prevalence of infertility in Canada. ... reproductive endocrinologist and co-director at Olive Fertility Centre, and ... and founder of Acubalance Wellness Centre will be speaking ...
(Date:3/3/2015)... 2015 -- vRad ( Virtual Radiologic ), the nation’s ... Arlene Sussman, MD, a highly regarded breast imaging and ... explore how telemedicine best practices allow for the access ... virtually anywhere. Click here to register for ... 4, 2015 at 1:00 pm CT. , Hospitals must ...
(Date:3/3/2015)... Dallas, Texas (PRWEB) March 03, 2015 ... will serve as chairman of the upcoming Dallas Rhinoplasty ... 2015. The three day symposium, which is attended by ... designed to provide surgeons with detailed information on current ... and revision rhinoplasty surgery . , The ...
(Date:3/3/2015)... 3, 2015) (PRWEB) March 03, 2015 ... an innovator in the travel industry for the past ... expansion plan. To fulfill his vision for the future ... 400 fun, exciting and well-compensated positions as travel sales ... news sales center planned for the Boynton Beach, Florida ...
Breaking Medicine News(10 mins):Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3
... doses of daily caffeine during pregnancy whether from ... an increased risk of miscarriage, according a new study ... controlled, for the first time, pregnancy-related symptoms of nausea, ... the determination of caffeines true effect on miscarriage risk. ...
... DALLAS Jan. 21, 2008 Findings by UT ... the potential benefits and side effects of the drug ... In todays online issue of Cancer, UT ... Institutes Prostate Cancer Prevention Trial, or PCPT. The trial, ...
... 1.5 million Americans, most of them women, suffer from ... the bodys own tissue. This week marks a significant ... the online publication of four new studies identifying genes ... Mary K.Crow, M.D., associate chief of the division of ...
... To Make Global Inroads ... on Decreasing Deaths from the Disease, DALLAS, Jan. 20 ... network of breast cancer survivors and,activists, this week welcomes a ... for a five-day intensive training of,trainers session called Course for ...
... route and available for comment, STAMFORD, Conn., Jan. ... medical supplies to Kenya in response,to the upheaval following ... over 600 people have been killed and over 250,000,have ... is due to,arrive on Saturday (January 19) and will ...
... added pressure on joints, study suggests , , FRIDAY, ... with osteoarthritis may also play a role in determining ... The findings, which included an analysis of the genomes ... a number of reasons, said study co-leader Goncalo Abecasis, ...
Cached Medicine News:Health News:New Kaiser Permanente study fortifies caffeine's link to miscarriage 2Health News:New Kaiser Permanente study fortifies caffeine's link to miscarriage 3Health News:Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend 2Health News:NEJM editorial on significance and limitations of new lupus gene expression research 2Health News:NEJM editorial on significance and limitations of new lupus gene expression research 3Health News:NEJM editorial on significance and limitations of new lupus gene expression research 4Health News:Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session 2Health News:Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session 3Health News:Genes Linked to Height Also Tied to Osteoarthritis Risk 2
... Ultra device consists of a non-compliant balloon ... mounted longitudinally on its outer surface. When ... the atherotomes score the plaque, creating initiation ... to as Atherotomy, allows dilatation of the ...
... Millar Mikro-Tip pressure intravascular catheters provide ... method of measuring pressures in the ... thromboresistant Mikro-Tip catheters are ideal for ... range in size from 2 to ...
... pressure intravascular catheters provide a simple, ... measuring pressures in the heart or ... catheters are ideal for high fidelity ... size from 2 to 7 French ...
... Millar Mikro-Tip pressure intravascular catheters provide ... method of measuring pressures in the ... thromboresistant Mikro-Tip catheters are ideal for ... range in size from 2 to ...
Medicine Products: